Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing elpipodect for Bipolarity.
Multiple locations, including Little RockThis study is completed in the United States. It is testing elpipodect for schizophrenia.
Multiple locations, including Garden GroveThis study was withdrawn. It is testing Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant for treatment-resistant depression.
Location not clearly listedThis study is completed in the United States. It is testing esketamine Nasal Spray, Administered for treatment-resistant depression.
Multiple locations, including BirminghamThis study is completed. It is testing Extended Release Extended-release (ER) OROS Paliperidone Tolerability, for schizophrenia.
Location not clearly listedThis study is completed in Japan. It is testing FK199B to Compare Efficacy With Zolpidem by Polysomnography for Bipolarity.
Multiple locations, including ChūbuThis study is completed in the United States. It is testing flexible Dose Brexpiprazole for PTSD.
Multiple locations, including TuscaloosaThis study is completed. It is testing flexibly Dosed Paliperidone Extended Release Tablets for schizophrenia.
Location not clearly listedThis study is completed in the United Kingdom, in Poland, and in Romania. It is testing GWP42003 for schizophrenia.
Multiple locations, including CzeladźThis study is completed. It is testing How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections for schizophrenia.
Location not clearly listedThis study is completed in the United States. It is testing infliximab for depression.
In AtlantaThis study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
Multiple locations, including BirminghamHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.